Javara
Private Company
Total funding raised: $25M
Overview
Javara is a private, US-based clinical research services company founded in 2018, pioneering a 'Clinical Research as a Care Option' (CRAACO) model. By embedding research infrastructure within established healthcare provider networks like Atrium Health and Privia Health, it seeks to solve chronic industry inefficiencies in patient recruitment and retention. This integrated approach targets faster, more diverse trial enrollment to reduce drug development timelines for its biopharma and CRO clients.
Technology Platform
An integrated, tech-enabled service platform that embeds clinical trial infrastructure into community healthcare systems. It utilizes centralized resources, standardized operations, and tools like an A.I. Screening Assistant to connect patients with trials through their existing providers.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Javara competes with traditional CROs (like IQVIA, PPD) and large site networks, but its integrated IRO model is differentiated. Direct competitors include other decentralized clinical trial (DCT) platform providers and niche CROs focusing on community integration, but Javara's deep, operational embedding within health systems creates a significant barrier to entry.